2025 is ONdrugDelivery’s 20th Anniversary Year! Read on to find out how your company can get involved…
ONdrugDelivery provides >131,000 annual active web users (including >18,000 opt-in e-newsletter readers per issue) plus 1,000 print readers per issue throughout global pharma/biopharma, with the latest, most pertinent industry information and intelligence about the drug delivery-related ideas, technologies, services and products the sector is developing. Trusted throughout the industry for its high-quality content from leading industry experts, ONdrugDelivery is a must for pharma and biotech industry professionals who need to know what’s going on in drug delivery.
Our readers have a predefined commercial interest in drug delivery – gain a presence in ONdrugDelivery to engage with them.
How to Gain a Presence in ONdrugDelivery
If your company’s activities are a fit with ONdrugDelivery’s specialist issue topics, and you need to access, engage and generate qualified leads from ONdrugDelivery’s readers, there are various ways of gaining a presence: five levels of placements, “Outstanding“, “Enhanced“, “Classic“, “Showcase” and “Essential Presence“; plus straight magazine and web ad options; and two types of article-only placement, non-promotional “Expert View” and, for university spin-outs and young start-ups, “Early Insight“.
Click the +‘s below to expand sections for full detail: There’s only ever ONE Outstanding Sponsor per issue of ONdrugDelivery so this top spot is offered on a strictly first-to-confirm basis. Outstanding Sponsorship includes: a prime positioned article (which can promote a commercial offering) PLUS prime positioned magazine adverts PLUS prime positioned web advert PLUS a range of additional branding, marketing and lead-generation benefits (full list below) across ONdrugDelivery’s global digital, magazine issue (print/PDF/flipper-reader) and social channels. As an ONdrugDelivery sponsor, your pages are for you exclusively, both online and in the magazine issue. We won’t place other companies’ ads or content on your pages. Sponsorship is a powerful and effective method of not only getting your technical, scientific, strategic and commercial messages across in full to the people you want to reach, but to yield actionable results by engaging with them. The Outstanding ONdrugDelivery sponsorship package – designed specifically to put you front and centre in front of your potential partners and clients – is an intelligent combination of prime positioned advertising, branding and editorial which serves to: There are only TWO Enhanced Sponsors per issue of ONdrugDelivery, so these placements are offered on a strictly first-to-confirm basis. Enhanced Sponsorship includes: a boosted position for your article (which can promote a commercial offering) PLUS prime positioned magazine adverts PLUS boosted positioning for you web advert PLUS a range of additional branding, marketing and lead-generation benefits (full list below) across ONdrugDelivery’s global digital, magazine issue (print/PDF/flipper-reader) and social channels, all boosted in prominence/positioning. As an ONdrugDelivery sponsor, your pages are for you exclusively, both online and in the magazine issue. We won’t place other companies’ ads or content on your pages. Sponsorship is a powerful and effective method of not only getting your technical, scientific, strategic and commercial messages across in full to the people you want to reach, but to yield actionable results by engaging with them. The Enhanced ONdrugDelivery sponsorship package – designed specifically to position you more prominently in front of your potential partners and clients – is an intelligent combination of prime positioned advertising, branding and editorial which serves to: Classic Sponsorship includes: an article (which can promote a commercial offering) PLUS a magazine advert PLUS a web advert PLUS a range of additional branding, marketing and lead-generation benefits (full list below) across ONdrugDelivery’s global digital, magazine issue (print/PDF/flipper-reader) and social channels. As an ONdrugDelivery sponsor, your pages are for you exclusively, both online and in the magazine issue. We won’t place other companies’ ads or content on your pages. Sponsorship is a powerful and effective method of not only getting your technical, scientific, strategic and commercial messages across in full to the people you want to reach, but to yield actionable results by engaging with them. The Classic ONdrugDelivery sponsorship package – designed specifically to grab the attention of your potential partners and clients – is an intelligent combination of advertising, branding and editorial which serves to: Take two pages in ONdrugDelivery to showcase any aspect of your offering – for example, your company, a product range, a platform, a brand, a single product, or solutions or services – to ONdrugDelivery’s readers. For companies requiring an emphatic presence but with limited budget or limited content available, with a Company Spotlight in the magazine, a web banner ad, e-newsletter mention and linking and a social post tag and mention, the “Essential” package really hits the mark. ONdrugDelivery Magazine can carry double-page spread, full-page, half-page vertical, half-page horizontal, third-of-a-page vertical (one col) and third-of-a-page horizontal advertisements. All ads are colour, by default they are right-hand-page positioned. Specific positioning requirements can always be considered. All ads appear in the print, PDF and e-reader versions of the magazine. ALL MAGAZINE AD BOOKINGS INCLUDE: Web Banner Advertisements Our digital advertising offering is focused on quality. Strictly limited positions are available and artwork with style and of a high standard is required. This ensures maximum quality, engagement, impact and value both of the website experience for our readers and of the space our advertisers purchase. A limited number of Leaderboard (728x90px) and Skyscraper (120x600px) web ad positions, linking to a URL of your choice (including a tracking URL if desired), with various page-specific positioning options (including specific drug-delivery topic-targeted options) are available for 3 month, 6 month and 12 month runs. Expert Views We welcome proposals for non-promotional article contributions. Not associated with advertising or sponsorship, these unbranded, non-paid submissions are written by recognised experts in the field. We call these articles Expert Views. Expert Views must be written by experts in the field who can deliver genuine value to readers within the scope of a given issue topic. Articles submitted on this basis are thought-leadership pieces, unbranded and non-promotional, up to 2,000 words, and include colour figures/diagrams and contact details. They must be as impartial as possible and must not be promotional / PR pieces. They cannot focus on one company’s product, technology or service offerings but they can mention these in the context of a review of a market or industry sector where other companies’ offerings in the space must also be mentioned. See previous Expert Views here. (You have to be logged-in to read Expert Views.) Expert Views are not promotional content – there are no fees associated with appearing in ONdrugDelivery on this basis. To Propose an Expert View submission, contact ONdrugDelivery’s Editor, James Arnold: Early Insights Designed to provide very early-stage commercial and academic innovations a platform, and to inform our readers about technologies at the earliest possible opportunity, Early Insights are up to 2,000 words, and include colour figures and diagrams and contact details. There is minimal branding on Early Insights (a small company / university logo in the contact box). Unlike Expert Views, Early Insights can focus on one company’s product, technology or service offering and indeed this is encouraged. Early Insights are open to academic organisations, spinouts and early start-ups. Commercial organisations can only normally submit one Early Insight to ONdrugDelivery and it should be the first or one of the very first times they are publicising the innovation. See examples of previous Early Insights here. Early Insights are not paid for content – there are no fees associated with appearing in ONdrugDelivery on this basis. To Propose an Early Insight submission, contact ONdrugDelivery’s Editor, James Arnold: 1. Outstanding Issue Sponsorship
“Outstanding” is the exclusive premium full-works package. Enjoy all the very best prime spots for your content item, magazine ads, web ads and branding, across all channels (print, digital, email and social) plus various extra benefits.
Outstanding Sponsorship Magazine Issue Benefits
Outstanding Sponsorship Digital Benefits
For Prices & Info, Click Here to Email Guy Furness
2. Enhanced Issue Sponsorship
The “Enhanced” package boosts the positioning of your content item, magazine ads, web ads and branding, to more prominent spots across all channels (print, digital, email and social) compared with “Classic” (below), plus various other boosted benefits.
Enhanced Sponsorship Magazine Issue Benefits
Enhanced Sponsorship Digital Benefits
to your article onlineFor Prices & Info, Click Here to Email Guy Furness
3. Classic Issue Sponsorship
“Classic” is simply our tried-and-trusted Magazine Issue + Digital Sponsorship package combining a winning combination of content, magazine ads, web ads and branding across all channels (print, digital, email and social) plus various extra benefits. It’s the way most companies appear in ONdrugDelivery, and represents excellent value for powerful multi-channel impact.
Classic Sponsorship Magazine Issue Benefits
Classic Sponsorship Digital Benefits
company or author pagesFor Prices & Info, Click Here to Email Guy Furness
4. Showcase
You might not have a full story to contribute, but you still want the powerful presence that a content item in the magazine ensures, on the website and in the e-newsletter, showcases are shorter than feature articles and just present factual information, rather than telling a story.
Magazine Issue Benefits
Digital Benefits
For More Info and Prices, Email Guy Furness
5. Essential Presence
Magazine Issue Benefits
Digital Benefits
6. Advertising
Magazine Advertisements
e-reader versions of the magazine7. Expert Views (non-promotional)
8. Early Insights (for university spin outs and very early start-ups)
SUMMARY / OVERVIEW
ONdrugDelivery has a 20-year heritage, an excellent reputation, regular loyal support from leading companies (from the very largest to the very smallest), and a global, engaged, combined print and digital readership.
There are 15 issues in 2025. Each issue of ONdrugDelivery is published:
1. in print and PDF/e-reader
2. in an e-newsletter to >18,000 recipients
3. online on our website
4. via social media (LinkedIn and X).
Readership is truly global – core readership geographically predominantly North American and European with a substantial proportion of readers throughout the world’s other major pharma markets (Japan, Israel, Australia, New Zealand and others), and in the fast-growing Asian and South American markets.
By job function, most of the readership comprises middle and senior decision makers (executives and scientists) working within the global pharmaceutical, biotechnology, specialty pharma, drug delivery and medical devices industries. (Regulators, academics, financial analysts, consultants and bankers are also among our readers.)
ONdrugDelivery’s core global Print +Digital readership, wide social media reach, and extensive bonus print conference distribution combine to make a compelling, tightly targeted, truly global promotional value proposal.
In which issues should your company appear?
For companies providing drug delivery-related products, technologies and services, the publications provide a platform from which to reach new clients and partners.
The high level of topic specificity gives an unparalleled degree of targeting.
Issue topics include:
- Ophthalmic Drug Delivery
- Pulmonary & Nasal Drug Delivery (2 issues a year)
- Novel Oral Delivery Systems
- Skin Drug Delivery: Dermal, Transdermal and Microneedles
- Connecting Drug Delivery
- Drug Delivery & Environmental Sustainability (2 issues a year)
- Industrialising Drug Delivery
- Injectable Drug Delivery
- Prefilled Syringes & Injection Devices (2 issues a year)
- Wearable Injectors
- Dual Chamber Delivery Systems (NEW Topic for 2025!)
- Delivering Gene & Cell Therapies (NEW Topic for 2025!)
Contact us today to boost your organisation’s B2B marketing and business development performance, driving new sales and partnerships, by featuring your organisation across ONdrugDelivery’s global digital, social and print channels.
Drug delivery is a global industry, ONdrugDelivery’s readership is global, and our reach is global. However, Frederick Furness Publishing is a family owned, highly customer-focused company dealing with niche topics. As such, we have a detailed knowledge of the drug delivery business and a very personal approach to meeting the needs of our sponsors and advertisers.
ONdrugDelivery can help your organisation boost its business development and partnering success!
Find out today how your company can benefit from reaching and engaging ONdrugDelivery’s readers! Contact Guy Furness, ONdrugDelivery’s Publisher:
For Prices & Info, Click Here to Email Guy Furness
Guy Furness
T: +44 1273 47 28 28
E: [email protected]
Or get the Media Pack & Prices 2025 PDF, here:
See what ondrugdelivery's readers and contributors think
ONdrugDelivery Magazine is a great resource that brings a lot of value to the work my team and I are doing in the area of drug delivery. The device-specific content as well as the broader discussions surrounding industry trends and issues are extremely informative and very well written.
Your website and publication is a great asset for me. I’d recommend your publication to my colleagues. I am sure that we will gain knowledge and update information through your timely report. Thanks for making it available.
I‘m working on the development of microparticles for the release of veterinary antibiotics, and polymeric nanoparticles for siRNA and chemotherapeutic delivery. ONdrugDelivery has been a very usefull platform to connect the scientific research, and marketed drug development.
I am extremely impressed with the comprehensive presentation of information and problem/solution points detailed ... Kudos to you for an extremely well written article with succinct and robust scientific body of knowledge.